OTLKW
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
OTLKW
Delisted
OTLKW was delisted on the 16th of February, 2022.
4 hedge funds and large institutions have $146K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2020 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
$163K
Puts
–
Net Calls
+$163K
Net Calls Change
+$163K
Top Buyers
No buyers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $93K | – | – | – |
|
|
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
| $29K | – | – | – |
|
|
PC
3
PointState Capital
New York
| $22K | – | – | – |
|
|
CIA
4
Compass Ion Advisors
Conshohocken,
Pennsylvania
| $2K | – | – | – |
|
|
CAM
5
Cormorant Asset Management
Boston,
Massachusetts
| – | -$54K | -416,666 | Closed |
|
|
MWNA
6
Marshall Wace North America
New York
| – | -$16K | -125,400 | Closed |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3K | -22,156 | Closed |
|